FSMDX
Price
$33.24
Change
-$0.01 (-0.03%)
Updated
May 9 closing price
Net Assets
37.69B
IRMAX
Price
$9.04
Change
-$0.00 (-0.00%)
Updated
May 9 closing price
Net Assets
801.85M
Ad is loading...

FSMDX vs IRMAX

Header iconFSMDX vs IRMAX Comparison
Open Charts FSMDX vs IRMAXBanner chart's image
Fidelity Mid Cap Index
Price$33.24
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets37.69B
Voya Russell Mid Cap Index Port A
Price$9.04
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets801.85M
FSMDX vs IRMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMDX vs. IRMAX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Buy and IRMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 37.7B vs. IRMAX (802M). FSMDX pays higher dividends than IRMAX: FSMDX (1.21) vs IRMAX (0.84). FSMDX was incepted earlier than IRMAX: FSMDX (14 years) vs IRMAX (17 years). IRMAX (1.04) is less costly to investors than FSMDX (0.03). IRMAX is a more actively managed with annual turnover of: 30.00 vs. FSMDX (8.00). FSMDX (0) and IRMAX (0) have matching initial minimum investment requirements. FSMDX annual gain was more profitable for investors over the last year : 5.71 vs. IRMAX (-16.44). FSMDX return over 5 years is better than : 77.81 vs. IRMAX (-13.51).
FSMDXIRMAXFSMDX / IRMAX
Total Expense Ratio0.030.903%
Annual Report Gross Expense Ratio0.031.042%
Fund Existence14 years17 years-
Gain YTD-1.540-14.35711%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets37.7B802M4,701%
Annual Yield % from dividends1.210.84143%
Returns for 1 year5.71-16.44-35%
Returns for 3 years30.95-17.02-182%
Returns for 5 years77.81-13.51-576%
Returns for 10 years101.90-38.00-268%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REREX56.360.29
+0.52%
American Funds Europacific Growth R4
FASEX52.07N/A
N/A
Nuveen Mid Cap Value 1 A
WAYEX16.54N/A
N/A
Waycross Managed Risk Equity Fund
BIVIX17.10N/A
N/A
Invenomic Institutional
WCEYX19.86N/A
N/A
Macquarie Core Equity Fund Class Y